Clinical trial
Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung Cancer
NCT00330044 · Sidney Kimmel Cancer Center at Thomas Jefferson University, Other · Completed
Key facts
| NCT number | NCT00330044 |
|---|---|
| Title | Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung Cancer |
| Official title | A Phase I Study of Premetrexed (Alimta) and Carboplatin and Radiation Therapy in Patients With Inoperable Non Small Cell Lung Cancer. |
| Lead sponsor | Sidney Kimmel Cancer Center at Thomas Jefferson University, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Inoperable Non Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Premetrexed (Alimta), Carboplatin |
| Enrollment | 18 |
| Start date | Apr 1, 2006 |
| Primary completion | Aug 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | May 25, 2006 |
| Last update posted | May 2, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: